Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$13.34
0.352.69%
At Close: -
$13.34
00.00%
After Hours: Aug 23, 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Inhibrx Biosciences (INBX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOverview Rating
Good
Inhibrx Biosciences (NASDAQ:INBX) Stock Quotes, Forecast and News Summary
Inhibrx Biosciences Stock (NASDAQ: INBX) stock price, news, charts, stock research, profile.
| Open | $13.92 |
| Close | $13.34 |
| Volume / Avg. | 281.84K / 357.97K |
| Day Range | $12.93 - $14.35 |
| 52 Wk Range | 10.80 - 39.79 |
| Market Cap | $193.11M |
| P/E Ratio | 0.11 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 52 |
| Short Interest | 2.13% |
| Days to Cover | 7.58 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Inhibrx Biosciences Inc.
Sector
Health Care
Industry
Biotechnology
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biolo...
Show More
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Inhibrx Biosciences (INBX) stock?
You can purchase shares of Inhibrx Biosciences (NASDAQ:INBX) through any online brokerage.
Who are Inhibrx Biosciences (INBX) competitors?
Other companies in Inhibrx Biosciences’s space includes: Molecular Partners (NASDAQ:MOLN), Macrogenics (NASDAQ:MGNX), Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA) and Zentalis Pharma (NASDAQ:ZNTL).
What is the forecast, or price target, for Inhibrx Biosciences (INBX) stock?
Inhibrx Biosciences has a consensus price target of $45.25.
What is the current price for Inhibrx Biosciences (INBX)?
The stock price for Inhibrx Biosciences (NASDAQ: INBX) is $13.34 last updated August 23, 2024 at 4:00 PM EDT.
Does Inhibrx Biosciences (INBX) pay a dividend?
There are no upcoming dividends for Inhibrx Biosciences.
When is Inhibrx Biosciences (NASDAQ:INBX) reporting earnings?
Inhibrx Biosciences’s Q2 earnings are confirmed for Tuesday, August 13, 2024.
Is Inhibrx Biosciences (INBX) going to split?
There is no upcoming split for Inhibrx Biosciences.
What sector and industry does Inhibrx Biosciences (INBX) operate in?
Inhibrx Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.